MTOR and cardiac hypertrophy: Recent research is dedicated to the investigation of downstream effector pathways involved in the progression of cardiac hypertrophy and heart failure, Akt and mammalian target of rapamycin (mTOR) are included (Aoyagi and Matsui 2011).